相关实验视频

Updated: May 27, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

一个新的五探 FISH 策略更好地为 BCP-ALL 的更全面和更具成本效益的风险分层提供了更好的设备

Manish K Singh¹, Arun S Nair¹, Akshita Pandey¹

¹Department of Hematology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India.

International journal of laboratory hematology

|February 17, 2025

概括

一个新的五探 FISH 策略为B细胞前体急性淋巴细胞白血病 (BCP-ALL) 提供了改善的风险分层. 这种方法提高了检测高超二位分体相比传统的三重三症探针.

科学领域:

血液学血液学血液学
分子诊断学分子诊断
在瘤学瘤学.

背景情况:

对B细胞前体急性淋巴细胞白血病 (BCP-ALL) 的治疗方案越来越多地根据遗传特征和治疗反应量身定制.
准确的风险分层对于优化BCP-ALL患者管理至关重要.
现有的诊断工具在全面识别遗传异常时可能存在局限性.

研究的目的:

引入和评估BCP-ALL风险分层的新型五探针光现场混合化 (FISH) 策略.
为了比较五探针FISH策略与三重三症探针策略在检测高超化症方面的有效性.
评估新策略在识别BCP-ALL中临床相关的遗传重组方面的能力.

主要方法:

使用五个探针的FISH小组对380例新诊断的BCP-ALL病例进行查.
该小组包括BCR::ABL1,ETV6::RUNX1融合,以及KMT2A,IgH和CRLF2重组的探测器.
与三重三症状体探针 (4p11/CEN10/17) 进行比较,用于在一组病例中检测形状.

主要成果:

五探针FISH策略将380名BCP-ALL患者中约三分之二的风险组分配给了风险组.
与三重三症探针策略相比,在75.5%的病例中观察到一致的结果.
三重三症探针未能在24.5%的患者中检测出高水平的超化;在5.3%的患者中发现了IgH重组 (非CRLF2).

结论:

拟议的五探 FISH 战略为 BCP-ALL.提供了更全面的风险分层.
这种新的策略证明了在识别高超体积症方面具有卓越的能力.
五探 FISH 方法还有助于检测 Ph 类 BCP-ALL 病例的子集.

关键词:

CRLF2 的重新安排.在IgH重新排列的过程中.五个探针 FISH 鱼类高水平的超二倍体积症.三重 trisomy 探测器探测器探测器

更多相关视频

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay

Published on: September 16, 2012

相关概念视频

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...